Skip to Main content Skip to Navigation
Journal articles

Could Mycolactone Inspire New Potent Analgesics? Perspectives and Pitfalls

Abstract : Pain currently represents the most common symptom for which medical attention is sought by patients. The available treatments have limited effectiveness and significant side-effects. In addition, most often, the duration of analgesia is short. Today, the handling of pain remains a major challenge. One promising alternative for the discovery of novel potent analgesics is to take inspiration from Mother Nature; in this context, the detailed investigation of the intriguing analgesia implemented in Buruli ulcer, an infectious disease caused by the bacterium Mycobacterium ulcerans and characterized by painless ulcerative lesions, seems particularly promising. More precisely, in this disease, the painless skin ulcers are caused by mycolactone, a polyketide lactone exotoxin. In fact, mycolactone exerts a wide range of effects on the host, besides being responsible for analgesia, as it has been shown notably to modulate the immune response or to provoke apoptosis. Several cellular mechanisms and different targets have been proposed to account for the analgesic effect of the toxin, such as nerve degeneration, the inhibition of inflammatory mediators and the activation of angiotensin II receptor 2. In this review, we discuss the current knowledge in the field, highlighting possible controversies. We first discuss the different pain-mimicking experimental models that were used to study the effect of mycolactone. We then detail the different variants of mycolactone that were used in such models. Overall, based on the results and the discussions, we conclude that the development of mycolactone-derived molecules can represent very promising perspectives for new analgesic drugs, which could be effective for specific pain indications. Key Contribution: This review develops arguments and issues around the development of new potent analgesic drugs derived from mycolactone, a toxin secreted by Mycobacterium ulcerans. To this end, the various modes of action of the toxin potentially underlying its analgesic properties are detailed and discussed in the context of various pain models-also concerning different variants of mycolactone.
Document type :
Journal articles
Complete list of metadata

Cited literature [140 references]  Display  Hide  Download
Contributor : Elizabeth Bernardo Connect in order to contact the contributor
Submitted on : Thursday, September 12, 2019 - 9:26:16 AM
Last modification on : Wednesday, April 27, 2022 - 4:55:33 AM
Long-term archiving on: : Saturday, February 8, 2020 - 5:27:40 AM


Publisher files allowed on an open archive


Distributed under a Creative Commons Attribution 4.0 International License



Marie-Line Reynaert, Denis Dupoiron, Edouard yeramian, Laurent C Marsollier, Priscille Brodin. Could Mycolactone Inspire New Potent Analgesics? Perspectives and Pitfalls. Toxins, MDPI, 2019, 11 (9), pp.516. ⟨10.3390/toxins11090516⟩. ⟨inserm-02284632⟩



Record views


Files downloads